2015, Number 5
<< Back Next >>
AMC 2015; 19 (5)
Amniotic fluid embolism: etiopathogenic realities and myths of a potentially fatal syndrome
Rodríguez GRM, Pérez SR, Roura CJO, Rodríguez PI
Language: Spanish
References: 30
Page: 528-538
PDF size: 349.66 Kb.
ABSTRACT
Background: amniotic fluid embolism is a catastrophic syndrome that takes place during the onset
of labor or during the labor. This syndrome of variable incidence is the second cause of maternal death in
many regions of the world. Rates up to 60 % are reported in developed countries. A more rigid investigation
has greatly increased the comprehension of this condition in the last two decades.
Objective: to set out the most recent elements that try to explain the etiology and physiopathology
of amniotic fluid embolism.
Method: a review o f 32 bibliographies, including journals and classic texts, w as made through the
Cuban virtual library, Lilacs, PubMed and Medline.
Development: amniotic fluid embolism is, from the physiopathological point of view , similar to the
systemic inflammatory response syndrome, and it is common in conditions like septic shock, in which the
abnormal response of the host is the main responsible for the clinical manifestations. Bimodal theory is the
rule: an early stage characterized by vasospasm and pulmonary hypertension and heart failure; and a late
stage where left heart failure, pulmonary edema, shock and coagulation disorders predominate.
Conclusions: the physiopathological basis o f this sequence o f hemodynamic changes seems to
entail a complex sequence of reactions that result from the abnormal activation of proinflammatory mediator
systems, similar to those present in the systemic inflammatory response syndrome that follows the almost
universal flow of fetal antigens to the maternal circulation during labor.
REFERENCES
1.- Gary A, Dildy LC, Stafford IP. Amniotic fluid em-bolism. En: Foley MR, Strong TH, Garite TJ, editors. Obstetric Intensive Care Manual. 3rd ed. New Yorck: McGraw- Hill Companies; 2011. p. 175-81.
2.- Clark LS. Embolia de líquido amniótico. Obstet Gynecol. 2014 Sep;123:337–48.
3.- Knight M, Tuffnell D, Brocklehurst P, Sparck P, Kurinczuk JJ. UK Obstetric Surveillance System. In-cidence and risk factors for amniotic-fluid embo-lism. Obtet Gynecol. 2010 May;115(5):910-7.
4.- Stolk KH, Zwart JJ, Schutte J, VAN Roosmalen J. Severe maternal morbidity and mortality from am-niotic fluid embolism in the Netherlands. Acta Ob-stet Gyncol Scand. 2012 Ago;91(8):991–5.
5.- Roberts CL, Algert CS, Knight M, Morris JM. Am-niotic fluid embolism in an Australian population-based cohort. BJOG. 2010 Oct;117(11):1417-21.
6.- Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J, et al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and rec-ommendations. BMC Pregnancy Childbirth [Internet] 2012 Feb [citado 12 Oct 2014];12:[aprox. 7 p.]. Disponible en: http://www.biomedcentral.com/1471-2393/12/7
7.- Kramer MS, Rouleau J, Liu S, Bartholomew S, Jo-seph KS. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic fluid embol-sim: incidence, risk factors, and impact on perinatal outcome. BJOG. 2012 Jun;119(7):874-9.
8.- Dildy GA, Belfort MA, Clark SL. Anaphylactoid syn-drome of pregnancy (amniotic fluid embolism). En: Belfort M, Saade G, Foley M, Phelan J, Dildy GA, edi-tors. Critical care obstetrics. 5th ed. Oxford (UK): Wiley-Blackwell; 2010. p. 466-74.
9.- Águila S. Embolismo de líquido amniótico (Síndrome anafilactoide del embarazo) En: Editorial Molinos Trade SA. Consenso de procederes diagnósti-cos y terapéuticos en Obstetricia y Perinatología. MINSAP: La Habana; 2010.
10.- Gary Cunningham F. Tromboembolic Disorders. En: Gary Cunningham F, Leveno KL, Bloom SL, Hauth JC, Gilstrap III LC, Wenstrom D, editors . Williams Ob-stetrics. 23th ed. New Yorck: McGraw-Hill Companies; 2010. p. 1013-30. 11.- Steiner PE, Luschbaugh CC. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA. 1941 Oct;117:1245-51.
12.- Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immu-nol [Internet]. 2012 Sep [citado 12 Oct 2014];2012:[aprox. 10 p.]. Disponible en: http://www.hindawi.com/journals/jir/2012/946576/
13.- Eastman NJ. Editorial comment. Obstet Gynecol Surv. 1948 Jun;3:35-6. 14.- Stolte L, Van Kessel H, Seelen J, Eskes T, Wagatsuma T. Fail utero produce the syndrome of am-niotic fluid embolism by infusion of amniotic fluid and meconium into monkeys. Am J Obstet Gynecol. 1967 Jun;98:694-7.
15.- Adamsons K, Mueller-Heubach E, Myer RE. The innocuousness of amniotic fluid infusion in the pregnan trhesus monkey. Am J Obstet Gynecol. 1971 Abr 1;109(7):977-84.
16.- Malvino E, Mcloughlin D, Muryan S. Embolia de líquido amniótico, criterios diagnósticos en dos casos fatales. MEDICINA (Buenos Aires). 2008;68(1):59-61.
17.- Hernández Iglesias R, Casacó Vázquez I, Silva Barrios E, Yora Orta R. Embolismo de líquido amnióti-co a propósito de un caso. Rev Cub Anest Rean. 2010;9(3):223-231.
18.- Báez AA, Girales EM, Pop AC. Crónica de una muerte "no" anunciada: un caso de embolismo por líquido amniótico. Rev Cub Med Int Emerg. 2004 Ene;3(1):40-5.
19.- Romero C, Luengo C, Huete A, Mercado M, Doug-nac A, Andresen M. Embolía por líquido amniótico: una puesta al día a propósito de un caso. Rev Chilena Med Int. 2005 Jul;20(1):38-41.
20.- Skerman J, Huckaby T, Otterson W. Emboli in pregnancy En: Datta S, editor. Anesthetic and Obstet-ric Management of High-Risk-Pregnancy. Mosby Year Book: St Louis MO; 1991. p. 495-521.
21.- Lacassie HJ. Anestesia Obstétrica UCI [Internet]. Chile: Universidad Católica de Chile; 2010 [citado 12 Oct 2014]. Disponible en: http://www.perinatal.sld.cu/docs/obstetricacritica/complicacionesgravesembarazolacassie.pdf
22.- Argelio Jiménez N, Pérez Buchillón R, Ardelio Her-rera R, Carmenate Álvarez L. Embolismo del líquido amniótico. Trabajo de revisión. MEDICIEGO [Internet]. 1996 [citado 12 Oct 2014];2(1):[aprox. 12 p.]. Dispo-nible en: http://bvs.sld.cu/revistas/mciego/vol2_01_96/a9_v2_0196.html
23.- Panchal S, Arria A, Harris A. Intensive care utili-zation during hospital admission for delivery. Anes-thesiology. 2000 Jun;92(6):1537-44.
24.- Romero R, Kadar N, Vaisbuch E, Hassan SS. Ma-ternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol. 2010 Ago 1;64(2):113-25.
25.- Rannou B, Rivard GE, GainsMJ, Bédard C. Intra-venous injection of autologous amniotic fluid induces transient thrombocytopenia in a gravid rabbit model of amniotic fluid embolism. Vet Clin Pathol. 2011 Dic;40(4):524-9.
26.- Sarig G, Klil-Drori AJ, Chap-Marshak D, Brenner B, Drugan A. Activation of coagulation in amniotic fluid during normal pregnancy. Thromb Res. 2011 Nov;128(5):490-5.
27.- Clark S. Critical Care Obstetrics. En: Dildy GA, Belfort MA, Saade GR, Phelan JP, Hankins GDV, edi-tors. Danforth´s Obstetrics and Gynecology. 9 ed. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 681-702.
28.- Ito F, Akasaka J, Koike N, Uekuri C, Shigemitsu A, Kobayashi H. Incidence, diagnosis and pathophysi-ology of amniotic fluid embolism. J Obstet Gynaecol. 2014 Oct;34(7):580-4.
29.- Nápoles Méndez D. Utilidad de las drogas vaso-activas en la paciente obstétrica en estado crítico. MEDISAN. 2014 Jun-Jul;18(7):978-92.
30.- Legrand M, Rossignol M, Dreux S, Luton D, Ventré C, Barranger E, et al. Diagnostic accuracy of insulin-like growth factor binding protein-1 for amni-otic fluid embolism. Crit Care Med. 2012 Sep;40:2059-63.
31.- Pacheco L, Saade GR, Costantine MM, Clark SL, Hankins GD. Massive transfusion protocols in obstet-rics. Am J Perinatol. 2013 Ene;30(1):1-4.
32.- Leighton BL, Wall MH, Lockhart EM, Phillips LE, Zatta AJ. Use of recombinant factor VIIa in patients with amniotic fluid embolism: a system-atic review of case reports. Anesthesiology. 2011 Dic;115(6):1201-8.